205 related articles for article (PubMed ID: 9571048)
1. Solution structure of the human Hck SH3 domain and identification of its ligand binding site.
Horita DA; Baldisseri DM; Zhang W; Altieri AS; Smithgall TE; Gmeiner WH; Byrd RA
J Mol Biol; 1998 Apr; 278(1):253-65. PubMed ID: 9571048
[TBL] [Abstract][Full Text] [Related]
2. Interaction of SH3 domain of Hck tyrosine kinase with cellular proteins containing proline-rich regions: evidence for modulation by unique domain.
Gouri BS; Swarup G
Indian J Biochem Biophys; 1997; 34(1-2):29-39. PubMed ID: 9343926
[TBL] [Abstract][Full Text] [Related]
3. The Ras GTPase-activating protein (GAP) is an SH3 domain-binding protein and substrate for the Src-related tyrosine kinase, Hck.
Briggs SD; Bryant SS; Jove R; Sanderson SD; Smithgall TE
J Biol Chem; 1995 Jun; 270(24):14718-24. PubMed ID: 7782336
[TBL] [Abstract][Full Text] [Related]
4. RT loop flexibility enhances the specificity of Src family SH3 domains for HIV-1 Nef.
Arold S; O'Brien R; Franken P; Strub MP; Hoh F; Dumas C; Ladbury JE
Biochemistry; 1998 Oct; 37(42):14683-91. PubMed ID: 9778343
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of the Src family kinase Hck SH3-SH2 linker regulatory region supports an SH3-dominant activation mechanism.
Alvarado JJ; Betts L; Moroco JA; Smithgall TE; Yeh JI
J Biol Chem; 2010 Nov; 285(46):35455-61. PubMed ID: 20810664
[TBL] [Abstract][Full Text] [Related]
6. SH3 domains with high affinity and engineered ligand specificities targeted to HIV-1 Nef.
Hiipakka M; Poikonen K; Saksela K
J Mol Biol; 1999 Nov; 293(5):1097-106. PubMed ID: 10547288
[TBL] [Abstract][Full Text] [Related]
7. SH3-dependent stimulation of Src-family kinase autophosphorylation without tail release from the SH2 domain in vivo.
Lerner EC; Smithgall TE
Nat Struct Biol; 2002 May; 9(5):365-9. PubMed ID: 11976726
[TBL] [Abstract][Full Text] [Related]
8. Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement.
Moarefi I; LaFevre-Bernt M; Sicheri F; Huse M; Lee CH; Kuriyan J; Miller WT
Nature; 1997 Feb; 385(6617):650-3. PubMed ID: 9024665
[TBL] [Abstract][Full Text] [Related]
9. Identification and biophysical assessment of the molecular recognition mechanisms between the human haemopoietic cell kinase Src homology domain 3 and ALG-2-interacting protein X.
Shi X; Opi S; Lugari A; Restouin A; Coursindel T; Parrot I; Perez J; Madore E; Zimmermann P; Corbeil J; Huang M; Arold ST; Collette Y; Morelli X
Biochem J; 2010 Oct; 431(1):93-102. PubMed ID: 20670214
[TBL] [Abstract][Full Text] [Related]
10. The 2.35 A crystal structure of the inactivated form of chicken Src: a dynamic molecule with multiple regulatory interactions.
Williams JC; Weijland A; Gonfloni S; Thompson A; Courtneidge SA; Superti-Furga G; Wierenga RK
J Mol Biol; 1997 Dec; 274(5):757-75. PubMed ID: 9405157
[TBL] [Abstract][Full Text] [Related]
11. Structure of a regulatory complex involving the Abl SH3 domain, the Crk SH2 domain, and a Crk-derived phosphopeptide.
Donaldson LW; Gish G; Pawson T; Kay LE; Forman-Kay JD
Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14053-8. PubMed ID: 12384576
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure of the Src family tyrosine kinase Hck.
Sicheri F; Moarefi I; Kuriyan J
Nature; 1997 Feb; 385(6617):602-9. PubMed ID: 9024658
[TBL] [Abstract][Full Text] [Related]
13. Solution structure of a Hck SH3 domain ligand complex reveals novel interaction modes.
Schmidt H; Hoffmann S; Tran T; Stoldt M; Stangler T; Wiesehan K; Willbold D
J Mol Biol; 2007 Feb; 365(5):1517-32. PubMed ID: 17141806
[TBL] [Abstract][Full Text] [Related]
14. Intramolecular regulatory interactions in the Src family kinase Hck probed by mutagenesis of a conserved tryptophan residue.
LaFevre-Bernt M; Sicheri F; Pico A; Porter M; Kuriyan J; Miller WT
J Biol Chem; 1998 Nov; 273(48):32129-34. PubMed ID: 9822689
[TBL] [Abstract][Full Text] [Related]
15. Reciprocal regulation of Hck activity by phosphorylation of Tyr(527) and Tyr(416). Effect of introducing a high affinity intramolecular SH2 ligand.
Porter M; Schindler T; Kuriyan J; Miller WT
J Biol Chem; 2000 Jan; 275(4):2721-6. PubMed ID: 10644735
[TBL] [Abstract][Full Text] [Related]
16. Solution structure of the human BTK SH3 domain complexed with a proline-rich peptide from p120cbl.
Tzeng SR; Lou YC; Pai MT; Jain ML; Cheng JW
J Biomol NMR; 2000 Apr; 16(4):303-12. PubMed ID: 10826882
[TBL] [Abstract][Full Text] [Related]
17. The role of the linker between the SH2 domain and catalytic domain in the regulation and function of Src.
Gonfloni S; Williams JC; Hattula K; Weijland A; Wierenga RK; Superti-Furga G
EMBO J; 1997 Dec; 16(24):7261-71. PubMed ID: 9405355
[TBL] [Abstract][Full Text] [Related]
18. Biochemical properties of the Cdc42-associated tyrosine kinase ACK1. Substrate specificity, authphosphorylation, and interaction with Hck.
Yokoyama N; Miller WT
J Biol Chem; 2003 Nov; 278(48):47713-23. PubMed ID: 14506255
[TBL] [Abstract][Full Text] [Related]
19. SH2-kinase linker mutations release Hck tyrosine kinase and transforming activities in Rat-2 fibroblasts.
Briggs SD; Smithgall TE
J Biol Chem; 1999 Sep; 274(37):26579-83. PubMed ID: 10473622
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel SH3 domain ligands for the Src family kinase Hck. Wiskott-Aldrich syndrome protein (WASP), WASP-interacting protein (WIP), and ELMO1.
Scott MP; Zappacosta F; Kim EY; Annan RS; Miller WT
J Biol Chem; 2002 Aug; 277(31):28238-46. PubMed ID: 12029088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
